Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Amit Gupta, the Chief Govt Officer of Cardlytics, Inc. (NASDAQ:CDLX), lately executed a collection of inventory transactions involving the corporate’s widespread inventory. On January 23, 2025, Gupta acquired 43,750 shares of widespread inventory by the conversion of restricted inventory items (RSUs), a transaction that didn’t contain any financial alternate. The transactions come at a time when Cardlytics, with a market capitalization of $197 million, has seen its inventory surge 22.8% over the previous week, based on InvestingPro information.
Subsequently, on January 24, 2025, Gupta offered 15,160 shares of Cardlytics widespread inventory at a median value of $3.92 per share, producing a complete of $59,427. The sale was carried out to fulfill tax withholding obligations associated to the vesting of RSUs, as famous within the submitting. Following these transactions, Gupta holds 215,494 shares of Cardlytics widespread inventory instantly. InvestingPro evaluation reveals the inventory has skilled vital volatility, with a 53.6% decline over the previous six months. Subscribers can entry 10 further ProTips and complete monetary metrics within the Professional Analysis Report, providing deeper insights into Cardlytics’ monetary well being and market place.
In different latest information, Cardlytics has launched its third-quarter monetary outcomes for 2024, indicating a constructive outlook for the ultimate quarter of the yr. The corporate is planning to boost its choices by new monetary establishment partnerships and operational and product initiatives. These plans intention to spice up Cardlytics’ monetary efficiency and market place. Nevertheless, the corporate acknowledges potential threat components that would result in completely different precise outcomes from the mentioned forecasts. Regardless of these uncertainties, Cardlytics stays optimistic about its future efficiency. These developments are a part of Cardlytics’ ongoing progress technique, with detailed monetary info obtainable within the firm’s press launch and SEC filings. As at all times, these forward-looking statements are topic to numerous dangers that would have an effect on precise outcomes.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.